117 related articles for article (PubMed ID: 24269889)
1. Skeletal muscle glycogen phosphorylase is irreversibly inhibited by mercury: molecular, cellular and kinetic aspects.
Xu X; Mathieu C; Boitard SE; Dairou J; Dupret JM; Agbulut O; Rodrigues-Lima F
FEBS Lett; 2014 Jan; 588(1):138-42. PubMed ID: 24269889
[TBL] [Abstract][Full Text] [Related]
2. The human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) is irreversibly inhibited by inorganic (Hg2+) and organic mercury (CH3Hg+): mechanism and kinetics.
Ragunathan N; Busi F; Pluvinage B; Sanfins E; Dupret JM; Rodrigues-Lima F; Dairou J
FEBS Lett; 2010 Aug; 584(15):3366-9. PubMed ID: 20591428
[TBL] [Abstract][Full Text] [Related]
3. Mouse monocytes (RAW CELLS) and the handling of cysteine and homocysteine S-conjugates of inorganic mercury and methylmercury.
Zalups RK; Koropatnick J; Joshee L
J Toxicol Environ Health A; 2007 May; 70(10):799-809. PubMed ID: 17454556
[TBL] [Abstract][Full Text] [Related]
4. Functional and molecular effects of mercury compounds on the human OCTN1 cation transporter: C50 and C136 are the targets for potent inhibition.
Galluccio M; Pochini L; Peta V; Iannì M; Scalise M; Indiveri C
Toxicol Sci; 2015 Mar; 144(1):105-13. PubMed ID: 25490951
[TBL] [Abstract][Full Text] [Related]
5. Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle.
Baker DJ; Timmons JA; Greenhaff PL
Diabetes; 2005 Aug; 54(8):2453-9. PubMed ID: 16046314
[TBL] [Abstract][Full Text] [Related]
6. Neurotoxicological effects of low-dose methylmercury and mercuric chloride in developing offspring mice.
Huang CF; Liu SH; Hsu CJ; Lin-Shiau SY
Toxicol Lett; 2011 Mar; 201(3):196-204. PubMed ID: 21195143
[TBL] [Abstract][Full Text] [Related]
7. The toxicology of mercury: Current research and emerging trends.
Bjørklund G; Dadar M; Mutter J; Aaseth J
Environ Res; 2017 Nov; 159():545-554. PubMed ID: 28889024
[TBL] [Abstract][Full Text] [Related]
8. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro.
de Luna N; Brull A; Guiu JM; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
Dis Model Mech; 2015 May; 8(5):467-72. PubMed ID: 25762569
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme.
Freeman S; Bartlett JB; Convey G; Hardern I; Teague JL; Loxham SJ; Allen JM; Poucher SM; Charles AD
Br J Pharmacol; 2006 Nov; 149(6):775-85. PubMed ID: 17016495
[TBL] [Abstract][Full Text] [Related]
10. [In vitro study of the nephrotoxic mechanism of mercuric chloride].
Aleo MF; Morandini F; Bettoni F; Tanganelli S; Vezzola A; Giuliani R; Steimberg N; Boniotti J; Bertasi B; Losio N; Apostoli P; Mazzoleni G
Med Lav; 2002; 93(3):267-78. PubMed ID: 12197277
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of ambradiolic acid as an inhibitor of glycogen phosphorylase.
Liu J; Zhang H; Zhu P; Wu X; Yao H; Ye W; Jiang J; Xu J
Fitoterapia; 2015 Jan; 100():50-5. PubMed ID: 25447165
[TBL] [Abstract][Full Text] [Related]
12. Effect of mercury ions on cysteine metabolism in Xenopus laevis tissues.
Sura P; Bronowicka-Adamska P; Furtak E; Wróbel M
Comp Biochem Physiol C Toxicol Pharmacol; 2011 Sep; 154(3):180-6. PubMed ID: 21605701
[TBL] [Abstract][Full Text] [Related]
13. Visual system manifestations due to systemic exposure to mercury.
El-Sherbeeny AM; Odom JV; Smith JE
Cutan Ocul Toxicol; 2006; 25(3):173-83. PubMed ID: 16980243
[TBL] [Abstract][Full Text] [Related]
14. Voltage-activated calcium channel currents of rat DRG neurons are reduced by mercuric chloride (HgCl2) and methylmercury (CH3HgCl).
Leonhardt R; Pekel M; Platt B; Haas HL; Büsselberg D
Neurotoxicology; 1996; 17(1):85-92. PubMed ID: 8784820
[TBL] [Abstract][Full Text] [Related]
15. Functional compartmentation of glycogen phosphorylase with creatine kinase and Ca2+ ATPase in skeletal muscle.
Field ML; Khan O; Abbaraju J; Clark JF
J Theor Biol; 2006 Jan; 238(2):257-68. PubMed ID: 16005021
[TBL] [Abstract][Full Text] [Related]
16. Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149.
Lerín C; Montell E; Nolasco T; García-Rocha M; Guinovart JJ; Gómez-Foix AM
Biochem J; 2004 Mar; 378(Pt 3):1073-7. PubMed ID: 14651477
[TBL] [Abstract][Full Text] [Related]
17. The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction.
Baker DJ; Greenhaff PL; MacInnes A; Timmons JA
Diabetes; 2006 Jun; 55(6):1855-61. PubMed ID: 16731853
[TBL] [Abstract][Full Text] [Related]
18. Toxicokinetics of mercuric chloride and methylmercuric chloride in mice.
Nielsen JB
J Toxicol Environ Health; 1992 Sep; 37(1):85-122. PubMed ID: 1522616
[TBL] [Abstract][Full Text] [Related]
19. Nitration of a critical tyrosine residue in the allosteric inhibitor site of muscle glycogen phosphorylase impairs its catalytic activity.
Dairou J; Pluvinage B; Noiran J; Petit E; Vinh J; Haddad I; Mary J; Dupret JM; Rodrigues-Lima F
J Mol Biol; 2007 Sep; 372(4):1009-1021. PubMed ID: 17689562
[TBL] [Abstract][Full Text] [Related]
20. Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: implications for treatment of mercury poisoning.
Carvalho CM; Lu J; Zhang X; Arnér ES; Holmgren A
FASEB J; 2011 Jan; 25(1):370-81. PubMed ID: 20810785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
